WEHI-164 Cells
USD 395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | The WEHI-164 cell line was originally established from a fibrosarcoma that developed in a BALB/c mouse following subcutaneous injections of 3-methylcholanthrene. This cell line is derived from mesenchymal tissue and demonstrates characteristics typical of fibroblast-like cells. WEHI-164 has been a critical tool in the study of cancer, providing insights particularly in the fields of tumor immunology and the cellular mechanisms of apoptosis. WEHI-164 cells are especially valued in research due to their responsiveness to cytokine-induced apoptosis, making them an important model for studying the interaction between cytokines and cancer cells. This sensitivity to cytokines like tumor necrosis factor (TNF) and TRAIL (TNF-related apoptosis-inducing ligand) positions the WEHI-164 cell line as a useful resource for exploring signaling pathways that mediate cell death and for screening potential anticancer therapies that could manipulate these pathways. Additionally, the cell line's fibroblast-like properties allow for studies on cell morphology, growth characteristics, and the tumor microenvironment, providing a more comprehensive understanding of tumor dynamics and interactions within the cellular matrix. Despite its extensive use in research, the WEHI-164 cell line exhibits several chromosomal aberrations, which is common among cells transformed by chemical carcinogenesis. These genetic instabilities are crucial for studies focused on understanding how genetic variations can influence cancer progression and response to treatments. The ongoing use of WEHI-164 in various research setups underscores its utility in advancing the knowledge of cancer biology and in the development of novel therapeutic approaches. |
|---|---|
| Organismo | Mouse |
| Enfermedad | Fibrosarcoma |
| Sinónimos | WEHI 164, WEHI164, WEHI 164 TC |
Características
| Raza/Subespecie | BALB/c |
|---|---|
| Morfología | Fibroblast-like |
| Tipo de célula | Fibroblast |
| Propiedades de crecimiento | Adherent |
Datos normativos
| Referencia | WEHI-164 (Cytion catalog number 400438) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 10090 |
| N.º de acceso de Cellosaurus | CVCL_2251 |
Datos biomoleculares
| Tumorigénico | Yes, in Balb/c mice |
|---|
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | Accutase |
| Subcultivo | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Densidad de siembra | 1 x 104 cells/cm2 |
| Renovación de fluidos | 2 to 3 times per week |
| Recuperación tras el deshielo | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 48 hours. |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 400438-413 | Certificado de análisis | 23. May. 2025 | 400438 |
| 400438-101225 | Certificado de análisis | 22. Jan. 2026 | 400438 |
-
Related products
Related products